Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Publicly Available Data Provide Evidence against NR1H3 R415Q Causing Multiple Sclerosis.
Mobitz type I and II atrioventricular blocks during fingolimod therapy.
Pediatric multiple sclerosis: Cognition and mood.
Listeria rhombencephalitis mimicking a demyelinating event in an immunocompetent young patient.
Zoledronate derivatives as potential inhibitors of uridine diphosphate-galactose ceramide galactosyltransferase 8: A combined molecular docking and dynamic study.
Novel therapeutic strategy for neurodegeneration by blocking Aβ seeding mediated aggregation in models of Alzheimer's disease.
[Expression of chemokine like factor-like myelin and lymphocyte and related proteins for vesicle trafficking and membrane link transmembrane domain-containing protein 2 in rats with varicocele].
Acute disseminated encephalomyelitis in a case of autoimmune haemolytic anaemia: a rare association.
Alpha-tocopherol ameliorates experimental autoimmune encephalomyelitis through the regulation of Th1 cells.
Rapid production of new oligodendrocytes is required in the earliest stages of motor-skill learning.
Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation.
THE EFFECT OF EDUCATIONAL INTERVENTION ON KNOWLEDGE AND SELF-EFFICACY FOR PAIN CONTROL IN PATIENTS WITH MULTIPLE SCLEROSIS.
Assessment of vitamin D status - a changing landscape.
[Diagnostics and treatment of trigeminal neuralgia].
Pembrolizumab-Induced Demyelinating Polyradiculoneuropathy.
Cognitive reserve in multiple sclerosis.
The axon as a physical structure in health and acute trauma.
Substrate reduction therapy for Krabbe's disease.
Intravenous Immunoglobulins Lower Inflammatory Gene Expression in Skin Biopsies of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.
Oligodendrocytes: Functioning in a Delicate Balance Between High Metabolic Requirements and Oxidative Damage.
Disability progression in aggressive multiple sclerosis.
Benefits from an autobiographical memory facilitation programme in relapsing-remitting multiple sclerosis patients: a clinical and neuroimaging study.
Observational data: Understanding the real MS world.
Evolving Concepts in Posterior Subthalamic Area Deep Brain Stimulation for Treatment of Tremor: Surgical Neuroanatomy and Practical Considerations.
Recurrent myelopathy and optic neuritis associated with systemic lupus erythematosus.
Pages
« first
‹ previous
…
775
776
777
778
779
780
781
782
783
…
next ›
last »